These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6781788)

  • 1. [Biochemical characteristics of a vaccine against hepatitis B].
    Adamowicz P; Yaniv M; Platel A; Muller L; Croissant O; Prunet P
    C R Seances Acad Sci III; 1981 Jan; 292(4):373-8. PubMed ID: 6781788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large scale purification of hepatitis B surface antigen (HBsAg).
    Barin F; André M; Goudeau A; Coursaget P; Maupas P
    Ann Microbiol (Paris); 1978 Jul; 129B(1):87-100. PubMed ID: 718020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hepatitis B surface antigen polypeptide (P31) with the receptor for polymerized human as well as chimpanzee albumins.
    Machida A; Kishimoto S; Ohnuma H; Miyamoto H; Baba K; Oda K; Nakamura T; Miyakawa Y; Mayumi M
    Gastroenterology; 1983 Aug; 85(2):268-74. PubMed ID: 6305755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis B vaccine: characterization of the polypeptides of hepatitis B surface antigen (author's transl)].
    Barin F; André M; Coursaget P; Gutman N; Hubert M; Goudeau A; Maupas P
    Ann Microbiol (Paris); 1979; 130 A(4):505-10. PubMed ID: 507623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of active preventive vaccination against hepatitis B with a German vaccine].
    Henning H; Laufs R; Kätzner K; Bredehorst R
    Z Gastroenterol; 1983 Mar; 21(3):111-4. PubMed ID: 6868717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constituents of HBs particle: characterization and purity of HBsAg in "HEVAC B".
    Gerfaux G; Platel A; Adamowicz P; Mazert MC
    Dev Biol Stand; 1983; 54():45-52. PubMed ID: 6228475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel hepatitis B virus variant S 129 (Gln-->Leu): lack of correlation between antigenicity and immunogenicity.
    Wu L; He JW; Yao X; Li HM; Wen YM
    J Med Virol; 1999 Dec; 59(4):424-30. PubMed ID: 10534722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBV and HCV infection in Japanese dental care workers.
    Nagao Y; Matsuoka H; Kawaguchi T; Ide T; Sata M
    Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of the "isolated anti-HBc" serological pattern determinated by the serological response to the vaccination against Hepatitis B].
    Coz Yataco A; Lozano Miranda A; Samalvides Cuba F; Antunez de Mayolo Ramis E
    Rev Gastroenterol Peru; 2005; 25(3):254-8. PubMed ID: 16237469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple purification procedure for hepatitis B surface antigen (HBs) by monoclonal antibody immunosorbent affinity chromatography.
    Juan CC; Lee SC
    Proc Natl Sci Counc Repub China B; 1986 Apr; 10(2):86-91. PubMed ID: 3749369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and virological evaluation of the detection of pre-S1 and pre-S2 antigens in serum from patients with chronic hepatitis B].
    Zoulim F; Capel F; Berthillon P; Trépo C; Petit MA
    Gastroenterol Clin Biol; 1995 Dec; 19(12):970-5. PubMed ID: 8729407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.
    Akbar SM; Furukawa S; Hasebe A; Horiike N; Michitaka K; Onji M
    Int J Mol Med; 2004 Aug; 14(2):295-9. PubMed ID: 15254781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Viral hepatitis B vaccine].
    Leone G; Melino G
    Clin Ter; 1983 Mar; 104(6):483-93. PubMed ID: 6851450
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis B: a controllable disease.
    Baker DA; Polk BF
    Obstet Gynecol; 1983 Jul; 62(1):105-8. PubMed ID: 6856210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunochemical structure of the hepatitis B surface antigen vaccine--I. Treatment of immobilized HBsAg by dissociation agents with or without enzymatic digestion and identification of polypeptides by protein blotting.
    Pillot J; Petit MA
    Mol Immunol; 1984 Jan; 21(1):53-60. PubMed ID: 6423972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
    Shiau AL; Murray K
    J Med Virol; 1997 Mar; 51(3):159-66. PubMed ID: 9139078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
    Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Electron microscopic study of the sera of hepatitis B surface antigen (HBs Ag) subjects (author's transl)].
    Monges B; Remacle JP; Monges G; Payan H
    Pathol Biol (Paris); 1981 Mar; 29(3):143-9. PubMed ID: 7017557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hepatitis B vaccine.
    Sampliner RE
    Ariz Med; 1983 Jun; 40(6):416-8. PubMed ID: 6882237
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
    Gandhi RT; Wurcel A; Lee H; McGovern B; Shopis J; Geary M; Sivamurthy R; Sax PE; Ukomadu C
    J Infect Dis; 2005 May; 191(9):1435-41. PubMed ID: 15809901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.